Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease.

Zhou, Jin; Tripathi, Madhulika; Sinha, Rohit A; Singh, Brijesh Kumar; Yen, Paul M

Zhou, Jin; Tripathi, Madhulika; Sinha, Rohit A; Singh, Brijesh Kumar; Yen, Paul M.

Afiliação

Zhou J; Program of Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, Singapore 169857, Singapore.
Tripathi M; Program of Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, Singapore 169857, Singapore.
Sinha RA; Department of Endocrinology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 226014, India.
Singh BK; Program of Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, Singapore 169857, Singapore.
Yen PM; Program of Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, Singapore 169857, Singapore.

Hepatoma Res ; 7: 11, 2021.

Article em En | MEDLINE | ID: mdl-33490737

Palavras-chave

Non-alcoholic fatty liver disease; gut microbiome; gut microbiota metabolites

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Prevencao_e_fatores_de_risco / Alcoolismo Base de dados: MEDLINE Idioma: En Revista: Hepatoma Res Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Singapura

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google